Clinical studies on hospitalized patients have suggesteda positive correlation between plasma ACE2 levels and the severityof COVID-19 infection, while ACE2 deficiencymay also worsen long COVID-19 symptoms, especially in patients withunderlying conditions such as diabetes, hypertension and heart disease. This evidence concerns the gene ACE2 and diabetes mellitus.